SecBot SecBot
EFFECT ·Filed Sep 23, 2026

AUTL

Autolus Therapeutics plc
NEUTRAL
Impact 4/10
Horizonweeks Processed1mo ago SEC9999999995-26-003037
IPO/offering going effective
Actionable Insight • Neutral

The shelf is now live — Perceptive can sell at any time. Monitor for a Form 4 or SC 13D/A indicating a reduction in Perceptive's stake, which would confirm selling pressure. The $1.9314 floor is ~8.5% below the $2.11 close at filing, so any near-term weakness toward that level could trigger accelerated sales.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
AUTL ▼ -16.92% at T+20d
NEUTRAL call -16.92% · α vs SPY -17.61% · entry $1.95 → $1.62
Next anchor: T+60d in 7w
Latest observation: T+22 -24.45% FF3 residual α
Entry = T+0 close
Sep 23, 2026
via day close
T+1d
-2.05%
call -2.05% · α -1.97%
$1.91
settled 5w ago
T+5d
-0.51%
call -0.51% · α +0.16%
$1.94
settled 27d ago
T+20d
-16.92%
call -16.92% · α -17.61%
$1.62
settled 6d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

The SEC declared effective Autolus Therapeutics' S-3 shelf registration (File No. 333-298910), filed 11 days earlier. The shelf registers 3,500,000 ADSs for resale by Perceptive Credit Holdings as a warrant sweetener from a July 2026 note purchase — a contractual obligation, not a new capital raise by the company. The effectiveness removes the last procedural barrier for Perceptive to sell shares at $1.9314, creating modest near-term overhang (~1.3% of shares outstanding) with no proceeds to Autolus.

Key Facts

  • Effectiveness date: September 22, 2026
  • Shelf file number: 333-298910
  • Registers 3,500,000 ADSs for resale by Perceptive Credit Holdings
  • Shares were issued as a warrant sweetener in a July 30, 2026 note purchase
  • Company receives no proceeds from the resale
  • Potential dilution of ~1.3% of shares outstanding
  • Resale price floor: $1.9314 per ADS

Financial Impact

Up to 3,500,000 ADSs (≈1.3% of shares outstanding) available for resale at $1.9314/ADS; company receives no proceeds

dilutionshare price

Risk Factors

  • Perceptive may sell shares into the market, creating downward price pressure
  • The resale overhang could cap upside until the shelf is substantially utilized or expires
  • No company proceeds from the offering — no capital benefit to offset dilution

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-003037
Document: 9999999995-26-003037-index.html9999999995-26-003037
Document: 9999999995-26-003037.txt9999999995-26-003037
14 reports for AUTL
Performance horizon
60% Hit rate @ T+5 3 of 5 directional calls Went positive at some point 3 of 5 best @ T+20▲ +29.12%Aug 3, 2026
Filters
Rows
Reports for AUTL — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
EFFECT
NEUTRAL ★ 4/10
$1.95 $1.94▼ −0.51%▲ +0.16%$1.53 (−21.54%)
Sep 11, 2026
6w ago
S-3
NEUTRAL ★ 4/10
$1.94 $1.94· 0.00%▼ −0.11%$1.53 (−21.13%)
Aug 11, 2026
10w ago
8-K
BULLISH ★ 7/10
$2.33 $2.29▼ −1.72%▼ −1.31%$1.53 (−34.33%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 7/10
$1.82 $2.07▲ +13.74%▲ +11.71%$1.53 (−15.93%)
Aug 3, 2026
12w ago
8-K
NEUTRAL ★ 6/10
$1.82 $2.07▲ +13.74%▲ +11.71%$1.53 (−15.93%)
Jun 12, 2026
19w ago
Press Release
NEUTRAL ★ 3/10
$1.56 $1.51▼ −3.21%▼ −3.88%$1.53 (−1.92%)
Jun 11, 2026
19w ago
Institutional Cluster
BEARISH ★ 6/10
$1.56 $1.53▲ +1.92%▲ +2.36%$1.53 (+1.92%)
Jun 9, 2026
19w ago
8-K
BEARISH ★ 7/10
$1.46 $1.50▼ −2.74%▼ −0.33%$1.53 (−4.79%)
May 21, 2026
22w ago
Press Release
NEUTRAL ★ 4/10
$1.70 $1.84▲ +8.24%▲ +6.58%$1.53 (−10.00%)
May 14, 2026
23w ago
8-K
MIXED ★ 6/10
$1.59 $1.65▲ +3.77%▲ +4.49%$1.53 (−3.77%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 2h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 23, 2026